Net Income

BridgeBio Pharma hosts a key investor webinar on its oral drug infigratinib for achondroplasia, setting the stage for crucial trial results in Q1 2026.

As robotaxis and self-driving trucks go commercial, a new group from Seeing Machines aims to solve the critical human trust and safety challenge.

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

A price increase on critical specialty chemicals by Trecora reveals mounting cost pressures that could ripple through automotive, construction, and water treatment.

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

Smart cart maker A2Z Cust2Mate pivots for hyper-growth as its visionary founder exits, leaving the CEO as interim chair to steer a global expansion strategy.

Bitcoin miner Bitfarms sells its last Latin American asset for $30M, pivoting fully to the booming North American AI and HPC infrastructure market.

Innocan Pharma is set to debut on the NYSE American, aiming to boost its innovative CBD drug delivery platform for non-opioid pain relief. What's next?

With strong growth and key acquisitions, Haemonetics' CEO will lay out the company's vision for 2026 at a high-stakes investor conference.

Amidst a market downturn, CNH brings in leaders from Rivian and Nikola to spearhead its ambitious transformation in autonomy, AI, and global operations.

Viomi Technology's $20M share repurchase program underscores faith in its 'Global Water' strategy, even as its stock faces a volatile market.

Online broker PU Prime partners with Argentina's AFA for a new campaign, but can a human-centric message overcome industry skepticism and user complaints?

Michelin is acquiring Cooley Group and Tex Tech Industries, pushing deeper into advanced materials for aerospace and healthcare as part of its 2030 strategy.

Ecovyst completes a major divestiture to slash debt and focus on its core, while Technip Energies acquires key assets to boost its energy transition goals.

Chinese auto giant GAC nearly tripled its exports in two years. Its secret? A hyper-localized strategy that is challenging incumbents worldwide.

Intelligent Bio Solutions raised crucial capital for its fingerprint drug test, but the deal's structure sent shares tumbling amid shareholder dilution fears.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

Insurtech firm PolicyStreet launches its largest promo yet, offering deep discounts and flexible payments to challenge traditional insurers in Malaysia.

As India's electric scooter sales surge, one insurer is shifting focus from policies to service, aiming to build trust with a new generation of riders.